\changetocdepth {2}
\babel@toc {english}{}\relax 
\contentsline {chapter}{\chapternumberline {1}Background \& Literature Overview}{1}{chapter.1}%
\contentsline {section}{\numberline {1.1}Differentiation Pathways in the Haematopoietic System}{2}{section.1.1}%
\contentsline {section}{\numberline {1.2}Acute Myeloid Leukaemia}{2}{section.1.2}%
\contentsline {subsection}{\numberline {1.2.1}Classification and Subtypes}{3}{subsection.1.2.1}%
\contentsline {subsubsection}{\numberline {1.2.1.1}The FAB classification system}{3}{subsubsection.1.2.1.1}%
\contentsline {subsubsection}{\numberline {1.2.1.2}The WHO classification system}{4}{subsubsection.1.2.1.2}%
\contentsline {subsection}{\numberline {1.2.2}Pathogenesis}{4}{subsection.1.2.2}%
\contentsline {subsubsection}{\numberline {1.2.2.1}Cytogenic Abnormalities}{4}{subsubsection.1.2.2.1}%
\contentsline {subsubsection}{\numberline {1.2.2.2}Genetic Abnormalities}{7}{subsubsection.1.2.2.2}%
\contentsline {subsection}{\numberline {1.2.3}Transcriptomic abnormalities}{8}{subsection.1.2.3}%
\contentsline {subsection}{\numberline {1.2.4} Treatment Methods}{8}{subsection.1.2.4}%
\contentsline {subsection}{\numberline {1.2.5}The Model Cell Line: HL-60 }{9}{subsection.1.2.5}%
\contentsline {section}{\numberline {1.3}Experimental Design}{10}{section.1.3}%
\contentsline {section}{\numberline {1.4}RNA-seq: \textit {in vitro}}{10}{section.1.4}%
\contentsline {subsection}{\numberline {1.4.1}RNA extraction}{11}{subsection.1.4.1}%
\contentsline {subsection}{\numberline {1.4.2}Library Preparation}{12}{subsection.1.4.2}%
\contentsline {subsection}{\numberline {1.4.3}Clonal amplification}{14}{subsection.1.4.3}%
\contentsline {subsection}{\numberline {1.4.4}Sequencing and Nucleobase Detection}{15}{subsection.1.4.4}%
\contentsline {section}{\numberline {1.5}RNA-seq: \textit {in silico}}{17}{section.1.5}%
\contentsline {subsection}{\numberline {1.5.1}Quality Control}{17}{subsection.1.5.1}%
\contentsline {subsubsection}{\numberline {1.5.1.1}FastQC}{18}{subsubsection.1.5.1.1}%
\contentsline {subsubsection}{\numberline {1.5.1.2}FastQScreen}{19}{subsubsection.1.5.1.2}%
\contentsline {subsubsection}{\numberline {1.5.1.3}MultiQC}{20}{subsubsection.1.5.1.3}%
\contentsline {subsection}{\numberline {1.5.2}Preprocessing}{20}{subsection.1.5.2}%
\contentsline {subsubsection}{\numberline {1.5.2.1}Cutadapt: Short reads and Adapter sequences}{20}{subsubsection.1.5.2.1}%
\contentsline {subsubsection}{\numberline {1.5.2.2}Prinseq++: Low complexity and No Basecalls}{21}{subsubsection.1.5.2.2}%
\contentsline {subsection}{\numberline {1.5.3}Alignment}{22}{subsection.1.5.3}%
\contentsline {subsubsection}{\numberline {1.5.3.1}STAR}{24}{subsubsection.1.5.3.1}%
\contentsline {subsection}{\numberline {1.5.4}Quantification}{25}{subsection.1.5.4}%
\contentsline {subsubsection}{\numberline {1.5.4.1}RSEM}{26}{subsubsection.1.5.4.1}%
\contentsline {subsection}{\numberline {1.5.5}Normalisation}{27}{subsection.1.5.5}%
\contentsline {subsubsection}{\numberline {1.5.5.1}Trimmed Mean of \textit {M}-values (TMM)}{28}{subsubsection.1.5.5.1}%
\contentsline {subsection}{\numberline {1.5.6}Differential Gene Expression (DGE) Analysis}{29}{subsection.1.5.6}%
\contentsline {subsubsection}{\numberline {1.5.6.1}EdgeR}{29}{subsubsection.1.5.6.1}%
\contentsline {subsection}{\numberline {1.5.7}Downstream Analysis}{30}{subsection.1.5.7}%
\contentsline {section}{\numberline {1.6}Evaluation Criteria}{30}{section.1.6}%
\contentsline {section}{\numberline {1.7}Related Work}{30}{section.1.7}%
\contentsline {section}{\numberline {1.8}Summary}{32}{section.1.8}%
\contentsline {chapter}{\chapternumberline {2}Materials \& Methods}{33}{chapter.2}%
\contentsline {section}{\numberline {2.1}Preliminary Study}{33}{section.2.1}%
\contentsline {subsection}{\numberline {2.1.1}Phenolic extraction}{33}{subsection.2.1.1}%
\contentsline {subsection}{\numberline {2.1.2}Cell Culturing and RNA extraction}{34}{subsection.2.1.2}%
\contentsline {subsection}{\numberline {2.1.3}Determination of RNA Quality and Sequencing}{34}{subsection.2.1.3}%
\contentsline {section}{\numberline {2.2}RNA-seq Pipeline}{35}{section.2.2}%
\contentsline {subsection}{\numberline {2.2.1}Quality Control}{37}{subsection.2.2.1}%
\contentsline {subsection}{\numberline {2.2.2}Preprocessing}{38}{subsection.2.2.2}%
\contentsline {subsection}{\numberline {2.2.3}Read alignment and Quantification}{39}{subsection.2.2.3}%
\contentsline {subsection}{\numberline {2.2.4}Reassessing the Quality}{40}{subsection.2.2.4}%
\contentsline {subsection}{\numberline {2.2.5}Normalisation and Differential Gene Expression}{40}{subsection.2.2.5}%
\contentsline {subsubsection}{\numberline {2.2.5.1}Filtering Low Count Genes}{41}{subsubsection.2.2.5.1}%
\contentsline {subsubsection}{\numberline {2.2.5.2}Gene Annotation}{41}{subsubsection.2.2.5.2}%
\contentsline {subsubsection}{\numberline {2.2.5.3}Normalisation}{42}{subsubsection.2.2.5.3}%
\contentsline {subsubsection}{\numberline {2.2.5.4}Adjusting p-values and Cut-offs}{43}{subsubsection.2.2.5.4}%
\contentsline {subsection}{\numberline {2.2.6}Functional analysis}{43}{subsection.2.2.6}%
\contentsline {section}{\numberline {2.3}Summary}{43}{section.2.3}%
\contentsline {chapter}{References}{45}{chapter*.37}%
